In the course of a screening program to find new platelet aggregation inhibitors, we discovered from the culture broth of Streptomyces sp. Q-1043 inhibitors against platelet aggregation induced with platelet aggregating factor (PAF), adenosine diphosphate (ADP), or collagen. This paper describes the fermentation, isolation and biological properties of these inhibitors.
Fermentation

Microorganism
The strain Q-1043 was classified in the genus Streptomyces on the basis of the following characteristics: Aerial mycelia were formed on the Bennett's agar and yeast extract -malt extract agar (the color of mature sporulated aerial mycelia was in the red-color series). Aerial mycelia used not to be formed on sucrose -nitrate agar, glucose -asparagine agar, glycerol -asparagine agar, inorganic salts -starch agar and oatmeal agar. Mature spore chains were predominantly straight to flexuous (section RF). Spore surface was smooth. Vegetative mycelial pigments ranged from brownish white to brownish black. Melanoid pigments were found. Analysis of whole cell hydrolysate of the strain Q-1043 showed that it contained diaminopimeric acid and glycine.
Fermentation
Spores of the strain of Streptomyces sp. Q-1043 were inoculated into 60ml of seed medium (pH 7.0) in a 500-ml Erlenmeyer flask. This medium consisted of glucose 1.0%, potato starch 2.0%, yeast extract 0.5%, Polypepton 0.5% and CaCO30.4%. The seed was cultured at 27°C for 72 hours on a rotary shaker (200 rpm) and then was transferred into a production vessel containing the medium. The fermentation was carried out at 27°C for 96 hours on a rotary shaker (220rpm).
Isolation
At harvest, the culture broth (5 liters) was adjusted to pH7.0 with dilute HC1 and centrifuged at 3,000rpm to remove the mycelial cake. The supernatant was extracted with ethyl acetate (6 liters). The ethyl acetate extract was washed with water and concentrated under reduced pressure. The resultant mass was diluted to 20ml with chloroform and applied onto a 300-ml bed of silica (Silica gel 60, E. Merck) equilibrated with chloroform. After elution with 1.5 columnvolumeof the same solvent, the columnwas eluted with chloroform -methanol (75 : 1). The eluate was monitored by both activity against Bacillus subtilis and TLC (Kieselgel 60 F254, E. Merck; chloroform-methanol, 19 : 1). Fractions of each 20 g were collected. Fractions (fraction No. 27~39) were combined and evaporated to dryness under reduced pressure to give a red-brownish mass, 220 mg. This consisted mainly of placetins A and Al. The fractions (fraction No. 40~54), containing mainly placetins B and Bl, were combined and evaporated to dryness under reduced pressure to give a reddish mass, 900mg. The combined fraction containing placetins A and Al was again chromatographed on preparative thin layer plates (Kieselgel 60 F254, E. Merck) using ethyl acetate as a development solvent. Fractions containing placetins A and Al were collected separately and extracted with ethyl acetate and each extract was concentrated to dryness under reduced pressure to give orange color crystals of pure placetin A, 13 mg and reddish color crystals of placetin Al, 23 mg. Similarly the fractions containing placetins B and Bl were chromatographed on preparative thin layer plates (Kieselgel 60 F254, E. Merck) using ethyl acetate as a development solvent. Fractions containing placetins B and Bl were collected separately and each fraction was extracted with ethyl acetate and the extract was Table 1 .
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Properties APR. 1990 The MICs of placetins A and B were determined against various bacteria by the 2-fold dilution method. As shown in Table 2 , placetins A and B exhibited weak inhibitory activities against Gram-positive bacteria, but placetins Al and Bl did not exhibit antimicrobial activity against B. subtilis ATCC6633 at a concentration of 1,000 /jg/ml.
Cytotoxicities 1) Placetins were tested for in vitro cytotoxicity against HeLa cells. HeLa cells (1 x 105 cells/ml) in the Eagle's minimumessential medium (MEM)containing 10% calf serum and the test sample solutions were planted into the wells of 96-well microtiter plates and incubated at 37°C for 72 hours with 5%CO2 under high humidity. The cytotoxicity of the test samples was determined by counting the viable cells. The cytotoxity is shown in Table 3 .
2) Placetins A and B were furthermore tested for in vitro cytotoxicities against L1210 and P388. The cytotoxicities of placetins A and B compared to that of mitomycin C in Table 4 .
Inhibitory Activities on Platelet Aggregation Nine volumes of blood were drawn from the central ear artery of male rabbit (Japan white, 3 kg) directly into plastic syringe containing 1 volume of 3.8% sodium citrate. The blood was centrifuged at 270 x g for 10 minutes at room temperature and the platelet rich plasma (PRP) was removed. The pellet was further centrifuged at 1,100 x g for 15 minutes. The supernatant was used as platelet poor plasma (PPP). The platelet concentration was adjusted to 5 x 105 cells/iul with PPP. Platelet aggregation was measured by the method1* of Born and Cross using a HEMATRACER(Nikon Bio Science, Japan). The extent of platelet aggregation was determined by the maximumchange of light transmission, assigning the transmission of unstimulated PRP to be 0% and that of PPP to be as 100%. The inhibitory activity of placetins on a rabbit platelet aggregation induced by various aggregating agents (ADP, platelet Furthermore placetins A and B exhibit strong cytotoxicities against P388, L1210 and HeLa. The physico-chemical properties of placetins show some similarities to those of kerriamycin2), urdamycin3), aquayamycin4) and OM-48425). However their structures are different from these known antibiotics.
